Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Feasibility of a Malaria Transmission Model Using PfSPZ Challenge
NCT04280692Phase 2Suspended
- Sponsor
- University of Oxford
- Start
- Aug 2022
- Primary completion
- Dec 2025
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of PfSPZ Challenge in malaria, sponsored by University of Oxford. Started Aug 2022; status: suspended.
02
Drugs
PfSPZ Challenge
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04280692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04280692.